Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform

BJU Int. 2018 May;121(5):680-683. doi: 10.1111/bju.14153. Epub 2018 Feb 28.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Androgen Antagonists / administration & dosage
  • Androgen Antagonists / pharmacology*
  • Estradiol / administration & dosage
  • Estradiol / pharmacology*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Transdermal Patch
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Estradiol

Associated data

  • ClinicalTrials.gov/NCT00303784
  • ClinicalTrials.gov/NCT00268476